Publications by authors named "Roger Meurer"

Claim this Profile
R
Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.
Zhu Chen, Edward A O'Neill, Roger D Meurer, Karen Gagen, Silvi Luell

J Cardiovasc Pharmacol Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered lipoprotein metabolism in P2Y(13) knockout mice.
Daniël Blom, Ting-Ting Yamin, Marie-France Champy, Mohammed Selloum, Elodie Bedu, Roger Meurer

Biochim Biophys Acta· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
Kobporn L Howell, Robert J DeVita, Margarita Garcia-Calvo, Roger D Meurer, JeanMarie Lisnock

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.
Ester Carballo-Jane, Zhu Chen, Edward O'Neill, Jun Wang, Charlotte Burton, Roger Meurer

Bioorg Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening.
Daniel R McMasters, Margarita Garcia-Calvo, Vladimir Maiorov, Margaret E McCann, Roger D Meurer

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose.
Cloud P Paweletz, Matthew C Wiener, Jeffrey R Sachs, Roger Meurer, Margaret S Wu

Proteomics· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
Thomas W Doebber, Linda J Kelly, Gaochao Zhou, Roger Meurer, Chhabi Biswas

Biochem Biophys Res Commun· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O-arylmandelic acids as highly selective human PPAR alpha/gamma agonists.
Alan D Adams, Zao Hu, Derek von Langen, Adonis Dadiz, Alex Elbrecht, Roger Meurer

Bioorg Med Chem Lett· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis